@entity1083 and Anemia Status Stratify the Survival of Early T2 XXXX .

@entity1 @entity4557 @entity986 @entity1083 @entity5 @entity957 @entity1082 @entity1349
OBJECTIVE: This study was designed to investigate the potentially prognostic indicators of early @entity957 ( @entity957 ), including @entity1082 ) status. METHODS: A total of 336 @entity1 with T2N0-1M0 LSCC were included in this study. Clinical data were collected from archival documents, and @entity1083 and @entity986 ( @entity986 ) expression were detected. RESULTS: A total of 32/318 cases of high-risk @entity1083 and 10/336 cases of @entity986 ( @entity986 ) overexpression were found. Three hundred eighteen @entity5 were classified into a three-class model according to @entity1083 and @entity986 ( @entity986 ) expression: class I, HPV+/ @entity986 +; class II, HPV+/ @entity986 -; and class III, HPV-/ @entity986 -. Class III had a trend of decreased @entity1349 ( @entity1349 ) (P  =  0.076) and a markedly low @entity4557 ( @entity4557 ) (P  =  0.022) compared with class I and class II. HPV-positive cases (class I plus class II) had a significantly longer @entity1349 (P  =  0.038) and @entity4557 (P  =  0.006). In multivariate analysis, HPV-positive (P  =  0.020), nonanemia (P = 0.011), and N0 stage (P  =  0.005) were significant predictors for high @entity4557 . But only HPV-positive (P  =  0.047) and nonanemia (P  <  0.001) were significant predictors for superior @entity1349 . CONCLUSION: A trend of discrete survival among HPV+/ @entity986 +, HPV+/ @entity986 -, and HPV-/ @entity986 classes was found in early @entity957 . We suggest that @entity1083 and hemoglobin level are the potential factors that can stratify outcome of early @entity957 .
